Product NDC: | 60505-0678 |
Proprietary Name: | cefepime |
Non Proprietary Name: | cefepime |
Active Ingredient(s): | 500 mg/1 & nbsp; cefepime |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-0678 |
Labeler Name: | APOTEX CORP. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065369 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070305 |
Package NDC: | 60505-0678-4 |
Package Description: | 10 VIAL in 1 BOX (60505-0678-4) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 60505-0678-4 |
Proprietary Name | cefepime |
Package Description | 10 VIAL in 1 BOX (60505-0678-4) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 60505-0678 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefepime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20070305 |
Marketing Category Name | ANDA |
Labeler Name | APOTEX CORP. |
Substance Name | CEFEPIME HYDROCHLORIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |